HEADER TRANSPORT PROTEIN 15-JUN-07 2QB4 TITLE CRYSTAL STRUCTURE ANALYSIS OF LEUT COMPLEXED WITH L-LEUCINE, SODIUM TITLE 2 AND DESIPRAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AQUIFEX AEOLICUS; SOURCE 3 ORGANISM_TAXID: 224324; SOURCE 4 STRAIN: VF5; SOURCE 5 GENE: SNF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B KEYWDS MEMBRANE PROTEIN, NEUROTRANSMITTER SODIUM SYMPORTER, OCCLUDED, KEYWDS 2 SECONDARY AMINE TRICYCLIC ANTIDEPRESSANT, DIBENZAZEPINE, KEYWDS 3 TRANSMEMBRANE, TRANSPORT, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.K.SINGH,A.YAMASHITA,E.GOUAUX REVDAT 6 30-AUG-23 2QB4 1 HETSYN REVDAT 5 29-JUL-20 2QB4 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 13-JUL-11 2QB4 1 VERSN REVDAT 3 24-FEB-09 2QB4 1 VERSN REVDAT 2 08-JAN-08 2QB4 1 JRNL REVDAT 1 21-AUG-07 2QB4 0 JRNL AUTH S.K.SINGH,A.YAMASHITA,E.GOUAUX JRNL TITL ANTIDEPRESSANT BINDING SITE IN A BACTERIAL HOMOLOGUE OF JRNL TITL 2 NEUROTRANSMITTER TRANSPORTERS. JRNL REF NATURE V. 448 952 2007 JRNL REFN ISSN 0028-0836 JRNL PMID 17687333 JRNL DOI 10.1038/NATURE06038 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.YAMASHITA,S.K.SINGH,T.KAWATE,Y.JIN,E.GOUAUX REMARK 1 TITL CRYSTAL STRUCTURE OF A BACTERIAL HOMOLOGUE OF REMARK 1 TITL 2 NA+/CL--DEPENDENT NEUROTRANSMITTER TRANSPORTERS REMARK 1 REF NATURE V. 437 215 2005 REMARK 1 REFN ISSN 0028-0836 REMARK 1 PMID 16041361 REMARK 1 DOI 10.1038/NATURE03978 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1897177.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 45626 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2265 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6158 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 290 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4043 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 151 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.47000 REMARK 3 B22 (A**2) : -1.88000 REMARK 3 B33 (A**2) : -4.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.86000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.050 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.290 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.850 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.770 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 65.09 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : B REMARK 3 PARAMETER FILE 4 : DESIP REMARK 3 PARAMETER FILE 5 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ION.TOP REMARK 3 TOPOLOGY FILE 3 : B REMARK 3 TOPOLOGY FILE 4 : DESIP REMARK 3 TOPOLOGY FILE 5 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 STRUCTURE IN ASYMMETRIC UNIT STARTS AT R5 BECAUSE OF DISORDER. REMARK 3 RESIDUES E129, T515, AND L516 ARE MODELED AS ALANINES BECAUSE REMARK 3 OF DISORDER. RESIDUES N133, A134, V517, P518, AND R519 ARE NOT REMARK 3 MODELED BECAUSE OF DISORDER. C-TERMINAL RESIDUES GTL MODELED REMARK 3 AS GAA BECAUSE OF DISORDER. REMARK 4 REMARK 4 2QB4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-AUG-07. REMARK 100 THE DEPOSITION ID IS D_1000043376. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : CHANNEL-CUT SI(111) CRYSTAL REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45802 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.57100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.490 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2A65 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17-22% PEGMME 550, 200 MM NACL, 100 MM REMARK 280 HEPES-NAOH, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.14500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.38500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.14500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.38500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THE BIOLOGICAL ASSEMBLY MIGHT NOT BE PHYSIOLOGICALLY REMARK 300 RELEVANT MAINLY BECAUSE OF THE RESULTS AUTHORS OBTAINED REMARK 300 IN SOLUTION. THE ACTUAL RESIDUES IN THE RELEVANT REMARK 300 TRANSMEMBRANE DOMAINS (TM9 AND TM12) ARE NOT CONSERVED REMARK 300 IN THE EUKARYOTIC HOMOLOGUES. AUTHORS ARE NOT 100% SURE REMARK 300 BECAUSE CROSSLINKING THE PROTEIN IN A LIPID BILAYER REMARK 300 HAS NOT BEEN PERFORMED. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 79.76886 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 80.80193 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 VAL A 3 REMARK 465 LYS A 4 REMARK 465 ASN A 133 REMARK 465 ALA A 134 REMARK 465 VAL A 517 REMARK 465 PRO A 518 REMARK 465 ARG A 519 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 129 CG CD OE1 OE2 REMARK 470 THR A 515 OG1 CG2 REMARK 470 LEU A 516 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 132 C - N - CA ANGL. DEV. = 16.5 DEGREES REMARK 500 PRO A 132 C - N - CD ANGL. DEV. = -26.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 54 -54.99 -126.33 REMARK 500 PRO A 160 41.69 -79.29 REMARK 500 PHE A 235 5.31 -60.37 REMARK 500 LEU A 238 -17.37 -48.36 REMARK 500 ILE A 297 -77.24 -97.61 REMARK 500 ILE A 325 -57.47 -120.13 REMARK 500 THR A 409 -72.87 -121.28 REMARK 500 TYR A 471 -46.80 -144.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE AUTHORS STATE THAT C2 NUMBERING IS IN CRYSTALLOGRAPHIC REMARK 600 NOTATION AND IT IS THE SAME AS C3 NUMBERING IN IUPAC. REMARK 600 REGARDING THE BOND ORDER DIFFERENCE FOR THE C5-C6 BOND, REMARK 600 THE AUTHORS USED THE TOPOLOGY AND PARAMETER FILES DERIVED REMARK 600 FROM THE SMALL MOLECULE CRYSTAL STRUCTURES OF CLOMIPRAMINE REMARK 600 AND IMIPRAMINE RATHER THAN THEORETICAL VALUES. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 751 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 20 O REMARK 620 2 VAL A 23 O 98.2 REMARK 620 3 ALA A 351 O 167.0 94.5 REMARK 620 4 THR A 354 OG1 91.4 114.0 85.5 REMARK 620 5 SER A 355 OG 84.8 98.5 91.0 147.6 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 752 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA A 22 O REMARK 620 2 ASN A 27 OD1 98.5 REMARK 620 3 THR A 254 OG1 166.6 94.2 REMARK 620 4 THR A 254 O 87.9 169.7 79.0 REMARK 620 5 ASN A 286 OD1 88.2 86.3 88.2 85.9 REMARK 620 6 LEU A 601 OXT 79.9 89.2 104.7 99.9 166.6 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2A65 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE AND SODIUM REMARK 900 RELATED ID: 2Q6H RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE, SODIUM, AND CLOMIPRAMINE REMARK 900 RELATED ID: 2Q72 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE, SODIUM, AND IMIPRAMINE REMARK 900 RELATED ID: 2QEI RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH L-ALANINE, CLOMIPRAMINE AND SODIUM DBREF 2QB4 A 1 513 UNP O67854 O67854_AQUAE 1 513 SEQADV 2QB4 GLY A 514 UNP O67854 CLONING ARTIFACT SEQADV 2QB4 THR A 515 UNP O67854 CLONING ARTIFACT SEQADV 2QB4 LEU A 516 UNP O67854 CLONING ARTIFACT SEQADV 2QB4 VAL A 517 UNP O67854 CLONING ARTIFACT SEQADV 2QB4 PRO A 518 UNP O67854 CLONING ARTIFACT SEQADV 2QB4 ARG A 519 UNP O67854 CLONING ARTIFACT SEQRES 1 A 519 MET GLU VAL LYS ARG GLU HIS TRP ALA THR ARG LEU GLY SEQRES 2 A 519 LEU ILE LEU ALA MET ALA GLY ASN ALA VAL GLY LEU GLY SEQRES 3 A 519 ASN PHE LEU ARG PHE PRO VAL GLN ALA ALA GLU ASN GLY SEQRES 4 A 519 GLY GLY ALA PHE MET ILE PRO TYR ILE ILE ALA PHE LEU SEQRES 5 A 519 LEU VAL GLY ILE PRO LEU MET TRP ILE GLU TRP ALA MET SEQRES 6 A 519 GLY ARG TYR GLY GLY ALA GLN GLY HIS GLY THR THR PRO SEQRES 7 A 519 ALA ILE PHE TYR LEU LEU TRP ARG ASN ARG PHE ALA LYS SEQRES 8 A 519 ILE LEU GLY VAL PHE GLY LEU TRP ILE PRO LEU VAL VAL SEQRES 9 A 519 ALA ILE TYR TYR VAL TYR ILE GLU SER TRP THR LEU GLY SEQRES 10 A 519 PHE ALA ILE LYS PHE LEU VAL GLY LEU VAL PRO GLU PRO SEQRES 11 A 519 PRO PRO ASN ALA THR ASP PRO ASP SER ILE LEU ARG PRO SEQRES 12 A 519 PHE LYS GLU PHE LEU TYR SER TYR ILE GLY VAL PRO LYS SEQRES 13 A 519 GLY ASP GLU PRO ILE LEU LYS PRO SER LEU PHE ALA TYR SEQRES 14 A 519 ILE VAL PHE LEU ILE THR MET PHE ILE ASN VAL SER ILE SEQRES 15 A 519 LEU ILE ARG GLY ILE SER LYS GLY ILE GLU ARG PHE ALA SEQRES 16 A 519 LYS ILE ALA MET PRO THR LEU PHE ILE LEU ALA VAL PHE SEQRES 17 A 519 LEU VAL ILE ARG VAL PHE LEU LEU GLU THR PRO ASN GLY SEQRES 18 A 519 THR ALA ALA ASP GLY LEU ASN PHE LEU TRP THR PRO ASP SEQRES 19 A 519 PHE GLU LYS LEU LYS ASP PRO GLY VAL TRP ILE ALA ALA SEQRES 20 A 519 VAL GLY GLN ILE PHE PHE THR LEU SER LEU GLY PHE GLY SEQRES 21 A 519 ALA ILE ILE THR TYR ALA SER TYR VAL ARG LYS ASP GLN SEQRES 22 A 519 ASP ILE VAL LEU SER GLY LEU THR ALA ALA THR LEU ASN SEQRES 23 A 519 GLU LYS ALA GLU VAL ILE LEU GLY GLY SER ILE SER ILE SEQRES 24 A 519 PRO ALA ALA VAL ALA PHE PHE GLY VAL ALA ASN ALA VAL SEQRES 25 A 519 ALA ILE ALA LYS ALA GLY ALA PHE ASN LEU GLY PHE ILE SEQRES 26 A 519 THR LEU PRO ALA ILE PHE SER GLN THR ALA GLY GLY THR SEQRES 27 A 519 PHE LEU GLY PHE LEU TRP PHE PHE LEU LEU PHE PHE ALA SEQRES 28 A 519 GLY LEU THR SER SER ILE ALA ILE MET GLN PRO MET ILE SEQRES 29 A 519 ALA PHE LEU GLU ASP GLU LEU LYS LEU SER ARG LYS HIS SEQRES 30 A 519 ALA VAL LEU TRP THR ALA ALA ILE VAL PHE PHE SER ALA SEQRES 31 A 519 HIS LEU VAL MET PHE LEU ASN LYS SER LEU ASP GLU MET SEQRES 32 A 519 ASP PHE TRP ALA GLY THR ILE GLY VAL VAL PHE PHE GLY SEQRES 33 A 519 LEU THR GLU LEU ILE ILE PHE PHE TRP ILE PHE GLY ALA SEQRES 34 A 519 ASP LYS ALA TRP GLU GLU ILE ASN ARG GLY GLY ILE ILE SEQRES 35 A 519 LYS VAL PRO ARG ILE TYR TYR TYR VAL MET ARG TYR ILE SEQRES 36 A 519 THR PRO ALA PHE LEU ALA VAL LEU LEU VAL VAL TRP ALA SEQRES 37 A 519 ARG GLU TYR ILE PRO LYS ILE MET GLU GLU THR HIS TRP SEQRES 38 A 519 THR VAL TRP ILE THR ARG PHE TYR ILE ILE GLY LEU PHE SEQRES 39 A 519 LEU PHE LEU THR PHE LEU VAL PHE LEU ALA GLU ARG ARG SEQRES 40 A 519 ARG ASN HIS GLU SER ALA GLY THR LEU VAL PRO ARG HET BOG A 701 20 HET BOG A 702 20 HET BOG A 703 20 HET BOG A 704 20 HET BOG A 705 20 HET NA A 751 1 HET NA A 752 1 HET LEU A 601 9 HET DSM A 801 20 HET DSM A 802 20 HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM NA SODIUM ION HETNAM LEU LEUCINE HETNAM DSM 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N- HETNAM 2 DSM METHYLPROPAN-1-AMINE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE HETSYN DSM DESIPRAMINE;NORPRAMIN FORMUL 2 BOG 5(C14 H28 O6) FORMUL 7 NA 2(NA 1+) FORMUL 9 LEU C6 H13 N O2 FORMUL 10 DSM 2(C18 H22 N2) FORMUL 12 HOH *141(H2 O) HELIX 1 1 THR A 10 VAL A 23 1 14 HELIX 2 2 GLY A 24 LEU A 29 1 6 HELIX 3 3 LEU A 29 ASN A 38 1 10 HELIX 4 4 GLY A 40 VAL A 54 1 15 HELIX 5 5 VAL A 54 ALA A 71 1 18 HELIX 6 6 THR A 76 TRP A 85 1 10 HELIX 7 7 ASN A 87 VAL A 95 1 9 HELIX 8 8 VAL A 95 VAL A 124 1 30 HELIX 9 9 ASP A 136 GLY A 153 1 18 HELIX 10 10 SER A 165 ILE A 184 1 20 HELIX 11 11 GLY A 190 LEU A 215 1 26 HELIX 12 12 ALA A 223 THR A 232 1 10 HELIX 13 13 ASP A 240 SER A 256 1 17 HELIX 14 14 GLY A 260 SER A 267 1 8 HELIX 15 15 ILE A 275 ILE A 292 1 18 HELIX 16 16 LEU A 293 GLY A 307 1 15 HELIX 17 17 GLY A 307 GLY A 318 1 12 HELIX 18 18 PHE A 320 ILE A 325 1 6 HELIX 19 19 ILE A 325 SER A 332 1 8 HELIX 20 20 GLY A 336 GLU A 370 1 35 HELIX 21 21 SER A 374 LEU A 396 1 23 HELIX 22 22 LYS A 398 ALA A 407 1 10 HELIX 23 23 THR A 409 TRP A 425 1 17 HELIX 24 24 GLY A 428 ARG A 438 1 11 HELIX 25 25 ARG A 446 TYR A 454 1 9 HELIX 26 26 TYR A 454 TYR A 471 1 18 HELIX 27 27 TYR A 471 GLU A 478 1 8 HELIX 28 28 THR A 482 ALA A 513 1 32 SHEET 1 A 2 GLU A 217 THR A 218 0 SHEET 2 A 2 GLY A 221 THR A 222 -1 O GLY A 221 N THR A 218 LINK O GLY A 20 NA NA A 751 1555 1555 2.23 LINK O ALA A 22 NA NA A 752 1555 1555 2.19 LINK O VAL A 23 NA NA A 751 1555 1555 2.18 LINK OD1 ASN A 27 NA NA A 752 1555 1555 2.34 LINK OG1 THR A 254 NA NA A 752 1555 1555 2.51 LINK O THR A 254 NA NA A 752 1555 1555 2.26 LINK OD1 ASN A 286 NA NA A 752 1555 1555 2.55 LINK O ALA A 351 NA NA A 751 1555 1555 2.28 LINK OG1 THR A 354 NA NA A 751 1555 1555 2.24 LINK OG SER A 355 NA NA A 751 1555 1555 2.35 LINK OXT LEU A 601 NA NA A 752 1555 1555 2.55 CRYST1 88.290 86.770 81.250 90.00 96.02 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011326 0.000000 0.001194 0.00000 SCALE2 0.000000 0.011525 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012376 0.00000